share_log

Avenue Therapeutics | 8-K: Current report

SEC announcement ·  Feb 23 16:25
Summary by Moomoo AI
Avenue Therapeutics, Inc. has officially increased its authorized shares from 75 million to 200 million, as detailed in a recent Form 8-K filing with the SEC. The stockholder consent for this increase was obtained on January 9, 2024, and the Certificate of Amendment was filed with the Delaware Secretary of State on February 20, 2024. This amendment to the company's Third Amended and Restated Certificate of Incorporation is documented in exhibit 3.1 of the report. The company's common stock is traded under the symbol ATXI on the Nasdaq Capital Market.
Avenue Therapeutics, Inc. has officially increased its authorized shares from 75 million to 200 million, as detailed in a recent Form 8-K filing with the SEC. The stockholder consent for this increase was obtained on January 9, 2024, and the Certificate of Amendment was filed with the Delaware Secretary of State on February 20, 2024. This amendment to the company's Third Amended and Restated Certificate of Incorporation is documented in exhibit 3.1 of the report. The company's common stock is traded under the symbol ATXI on the Nasdaq Capital Market.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more